The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection

E. H. Buster; B. C. Baak; C.M. Bakker; U. H. Beuers; J. T. Brouwer; J.P. Drenth; K.J. van Erpecum; B. van Hoek; P. Honkoop; M.J. Kerbert Dreteler; G.H. Koek; K. M. van Nieuwkerk; H. van Soest; B. W. van der Spek; A.C. Tan; J.M. Vrolijk; H. Janssen

The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection

E. H. Buster, B. C. Baak, C.M. Bakker, U. H. Beuers, J. T. Brouwer, J.P. Drenth, K.J. van Erpecum, B. van Hoek, P. Honkoop, M.J. Kerbert Dreteler, G.H. Koek, K. M. van Nieuwkerk, H. van Soest, B. W. van der Spek, A.C. Tan, J.M. Vrolijk, H. Janssen^*

^*Corresponding author for this work

Interne Geneeskunde

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance.

Original language	English
Pages (from-to)	381-385
Journal	Netherlands Journal of Medicine
Volume	70
Issue number	8
Publication status	Published - 1 Jan 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23065990

Cite this

Buster, E. H., Baak, B. C., Bakker, C. M., Beuers, U. H., Brouwer, J. T., Drenth, J. P., van Erpecum, K. J., van Hoek, B., Honkoop, P., Kerbert Dreteler, M. J., Koek, G. H., van Nieuwkerk, K. M., van Soest, H., van der Spek, B. W., Tan, A. C., Vrolijk, J. M., & Janssen, H. (2012). The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection. Netherlands Journal of Medicine, 70(8), 381-385. http://www.ncbi.nlm.nih.gov/pubmed/23065990

@article{928d6fe8f6c540eaa60bc33cbf3edfdc,

title = "The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection",

abstract = "In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance.",

author = "Buster, {E. H.} and Baak, {B. C.} and C.M. Bakker and Beuers, {U. H.} and Brouwer, {J. T.} and J.P. Drenth and {van Erpecum}, K.J. and {van Hoek}, B. and P. Honkoop and {Kerbert Dreteler}, M.J. and G.H. Koek and {van Nieuwkerk}, {K. M.} and {van Soest}, H. and {van der Spek}, {B. W.} and A.C. Tan and J.M. Vrolijk and H. Janssen",

year = "2012",

month = jan,

day = "1",

language = "English",

volume = "70",

pages = "381--385",

journal = "Netherlands Journal of Medicine",

issn = "0300-2977",

publisher = "Van Zuiden Communications",

number = "8",

}

Buster, EH, Baak, BC, Bakker, CM, Beuers, UH, Brouwer, JT, Drenth, JP, van Erpecum, KJ, van Hoek, B, Honkoop, P, Kerbert Dreteler, MJ, Koek, GH, van Nieuwkerk, KM, van Soest, H, van der Spek, BW, Tan, AC, Vrolijk, JM & Janssen, H 2012, 'The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection', Netherlands Journal of Medicine, vol. 70, no. 8, pp. 381-385. <http://www.ncbi.nlm.nih.gov/pubmed/23065990>

TY - JOUR

T1 - The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection

AU - Buster, E. H.

AU - Baak, B. C.

AU - Bakker, C.M.

AU - Beuers, U. H.

AU - Brouwer, J. T.

AU - Drenth, J.P.

AU - van Erpecum, K.J.

AU - van Hoek, B.

AU - Honkoop, P.

AU - Kerbert Dreteler, M.J.

AU - Koek, G.H.

AU - van Nieuwkerk, K. M.

AU - van Soest, H.

AU - van der Spek, B. W.

AU - Tan, A.C.

AU - Vrolijk, J.M.

AU - Janssen, H.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance.

AB - In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance.

M3 - Article

SN - 0300-2977

VL - 70

SP - 381

EP - 385

JO - Netherlands Journal of Medicine

JF - Netherlands Journal of Medicine

IS - 8

ER -

The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection

Abstract

Access to Document

Fingerprint

Cite this